Jacobus Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Jacobus Wealth Management's BMY Position: Q3 2017 in Review
Jacobus Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q3 2017, selling an estimated $26K and leaving 36,950 shares worth $2.35M. The position accounts for 0.62% of the portfolio, ranked #43.
Jacobus Wealth Management first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.81M in Q2 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Jacobus Wealth Management held 36,950 shares of Bristol-Myers Squibb worth $2.35M as of Q3 2017.
- Jacobus Wealth Management sold 445 Bristol-Myers Squibb shares in Q3 2017, an estimated $26K.
- Bristol-Myers Squibb made up 0.62% of Jacobus Wealth Management's portfolio in Q3 2017, its #43 holding.
- Jacobus Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
- Jacobus Wealth Management's Bristol-Myers Squibb position peaked at $3.81M in Q2 2016.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Jacobus Wealth Management's 13F filing for Q3 2017, filed 31 Oct 2017.